Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group
CONCLUSION: These GTH consensus recommendations provide guidance to physicians on the use of emicizumab in AHA and follow the results of clinical trials that have shown emicizumab is effective in preventing bleeding in AHA.PMID:38049124 | DOI:10.1055/a-2197-9738 (Source: Hamostaseologie)
Source: Hamostaseologie - December 4, 2023 Category: Hematology Authors: Christian Pfrepper Robert Klamroth Johannes Oldenburg Katharina Holstein Hermann Eichler Christina Hart Patrick Moehnle Kristina Schilling Karolin Trautmann-Grill Mohammed Alrifai Cihan Ay Wolfgang Miesbach Paul Knoebl Andreas Tiede Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
This article gives an overview of current diagnostic and therapeutic strategies.PMID:37992729 | DOI:10.1055/a-2178-6670 (Source: Hamostaseologie)
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Katja S M ühlberg Source Type: research
Cancer-Associated Venous Thromboembolism-Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline
Hamostaseologie. 2023 Nov 22. doi: 10.1055/a-2178-6508. Online ahead of print.ABSTRACTPatients with cancer are prone to develop venous thromboembolism (VTE) with negative impact on quality of life, morbidity, and mortality. Treatment of established VTE is often complex in patients with cancer. Treatment of cancer-associated VTE (CAT) basically comprises initial and maintenance treatment, for 3 to 6 months, secondary preventions, and treatment in special situations. Therapeutic anticoagulation is the treatment of choice in CAT. In addition to the efficacy and safety of low-molecular-weight heparin (LMWH) that had been recom...
Source: Hamostaseologie - November 22, 2023 Category: Hematology Authors: Hanno Riess Jan Beyer-Westendorf Uwe Pelzer Robert Klamroth Birgit Linnemann Source Type: research
